Towards reproducible computational drug discovery

被引:117
作者
Schaduangrat, Nalini [1 ]
Lampa, Samuel [2 ]
Simeon, Saw [3 ]
Gleeson, Matthew Paul [4 ]
Spjuth, Ola [2 ]
Nantasenamat, Chanin [1 ]
机构
[1] Mahidol Univ, Ctr Data Min & Biomed Informat, Fac Med Technol, Bangkok 10700, Thailand
[2] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden
[3] Kasetsart Univ, Interdisciplinary Grad Program Biosci, Fac Sci, Bangkok 10900, Thailand
[4] King Mongkuts Inst Technol Ladkrabang, Dept Biomed Engn, Fac Engn, Bangkok 10520, Thailand
关键词
Reproducibility; Reproducible research; Drug discovery; Drug design; Open science; Open data; Data sharing; Data science; Bioinformatics; Cheminformatics; SYSTEMS BIOLOGY; IN-SILICO; MEDICINAL CHEMISTRY; COMMUNITY STANDARD; STRUCTURAL ALERTS; WEB SERVER; BIG DATA; 3D QSAR; BIOINFORMATICS; SOFTWARE;
D O I
10.1186/s13321-020-0408-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code.
引用
收藏
页数:30
相关论文
共 281 条
[1]   Low Data Drug Discovery with One-Shot Learning [J].
Altae-Tran, Han ;
Ramsundar, Bharath ;
Pappu, Aneesh S. ;
Pande, Vijay .
ACS CENTRAL SCIENCE, 2017, 3 (04) :283-293
[2]   Large-scale ligand-based predictive modelling using support vector machines [J].
Alvarsson, Jonathan ;
Lampa, Samuel ;
Schaal, Wesley ;
Andersson, Claes ;
Wikberg, Jarl E. S. ;
Spjuth, Ola .
JOURNAL OF CHEMINFORMATICS, 2016, 8
[3]  
Alves VM, 2016, GREEN CHEM, V18, P4348, DOI [10.1039/C6GC01492E, 10.1039/c6gc01492e]
[4]   Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space [J].
Alvim-Gaston, Maria ;
Grese, Timothy ;
Mahoui, Abdelaziz ;
Palkowitz, Alan D. ;
Pineiro-Nunez, Marta ;
Watson, Ian .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (03) :294-303
[5]  
[Anonymous], CODE
[6]  
[Anonymous], BIND
[7]  
[Anonymous], 2019, Scientific Data
[8]  
[Anonymous], CDS NEWSLETTER
[9]  
[Anonymous], ASS SEC GIT SEC SOFT
[10]  
[Anonymous], SILICO DRUG DESIGN